{"organizations": [], "uuid": "b6650015116e7c576d9eb90d73220167c6ca6047", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180418.html", "section_title": "Archive News &amp; Video for Wednesday, 18 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-abbott-q1-gaap-earnings-per-share/brief-abbott-q1-gaap-earnings-per-share-0-23-from-continuing-operations-idUSASC09W9H", "country": "US", "domain_rank": 408, "title": "BRIEF-Abbott Q1 GAAP Earnings Per Share $0.23 From Continuing Operations", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-18T20:00:00.000+03:00", "replies_count": 0, "uuid": "b6650015116e7c576d9eb90d73220167c6ca6047"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-abbott-q1-gaap-earnings-per-share/brief-abbott-q1-gaap-earnings-per-share-0-23-from-continuing-operations-idUSASC09W9H", "ord_in_thread": 0, "title": "BRIEF-Abbott Q1 GAAP Earnings Per Share $0.23 From Continuing Operations", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "abbott laboratories", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 18 (Reuters) - Abbott Laboratories:\n* ABBOTT REPORTS FIRST-QUARTER 2018 RESULTS\n* Q1 GAAP EARNINGS PER SHARE $0.23 FROM CONTINUING OPERATIONS\n* Q1 EARNINGS PER SHARE VIEW $0.58 — THOMSON REUTERS I/B/E/S\n* SEES Q2 ADJUSTED EARNINGS PER SHARE $0.70 TO $0.72 FROM CONTINUING OPERATIONS EXCLUDING ITEMS\n* SEES FY 2018 ADJUSTED EARNINGS PER SHARE $2.80 TO $2.90 FROM CONTINUING OPERATIONS\n* SEES Q2 2018 GAAP EARNINGS PER SHARE $0.33 TO $0.35 FROM CONTINUING OPERATIONS\n* SEES FY 2018 GAAP EARNINGS PER SHARE $1.23 TO $1.33 FROM CONTINUING OPERATIONS\n* Q1 ADJUSTED EARNINGS PER SHARE $0.59 FROM CONTINUING OPERATIONS EXCLUDING ITEMS\n* Q2 EARNINGS PER SHARE VIEW $0.71 — THOMSON REUTERS I/B/E/S\n* FY2018 EARNINGS PER SHARE VIEW $2.86 — THOMSON REUTERS I/B/E/S\n* QTRLY TOTAL NUTRITION SALES $ 1,756 MILLION VERSUS $1,642 MILLION REPORTED LAST YEAR\n* QTRLY TOTAL DIAGNOSTICS SALES $ 1,837 MILLION VERSUS $1,158 MILLION REPORTED LAST YEAR\n* FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2018 OF APPROXIMATELY $1.57 PER SHARE\n* QTRLY TOTAL VASCULAR SALES $739 MILLION VERSUS $703 MILLION REPORTED LAST YEAR\n* FORECASTS SPECIFIED ITEMS FOR Q2 2018 OF $0.37/SHARE * QTRLY TOTAL PEDIATRIC SALES $994 MILLION VERSUS $927 MILLION REPORTED LAST YEAR\n* ABBOTT - FIRST-QUARTER WORLDWIDE SALES OF $7.4 BILLION INCREASED 16.7 PERCENT ON A REPORTED BASIS AND 6.9 PERCENT ON AN ORGANIC BASIS\n* Q1 REVENUE VIEW $7.29 BILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-18T20:00:00.000+03:00", "crawled": "2018-04-19T15:12:46.017+03:00", "highlightTitle": ""}